BC
TMO icon

Belmont Capital’s Thermo Fisher Scientific TMO Stock Holding History

Belmont Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$203K Hold
500
– – 0.03% 123
2025
Q1 		$249K Buy
+500
New +$271K 0.04% 111

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Belmont Capital's TMO Position: Q2 2025 in Review

Belmont Capital held its Thermo Fisher Scientific (TMO) position steady in Q2 2025 at 500 shares worth $203K. The position accounts for 0.03% of the portfolio, ranked #123.

Belmont Capital first reported a position in TMO in Q1 2025 and has held it in 2 quarters since. The position peaked at $249K in Q1 2025. 2,454 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Belmont Capital held 500 shares of Thermo Fisher Scientific worth $203K as of Q2 2025.
  • Belmont Capital left its Thermo Fisher Scientific share count unchanged in Q2 2025.
  • Thermo Fisher Scientific made up 0.03% of Belmont Capital's portfolio in Q2 2025, its #123 holding.
  • Belmont Capital first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 2 quarters since.
  • Belmont Capital's Thermo Fisher Scientific position peaked at $249K in Q1 2025.
  • 2,454 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Belmont Capital's 13F filing for Q2 2025, filed 12 Aug 2025.